文献
J-GLOBAL ID:202202264164423610
整理番号:22A0897711
Anthrax毒素受容体2はMETエキソン14スキッピング変異を伴う非小細胞肺癌の潜在的治療標的である【JST・京大機械翻訳】
Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations
著者 (5件):
Yamaguchi Miki
(Department of Molecular Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan)
,
Hirai Sachie
(Department of Molecular Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan)
,
Idogawa Masashi
(Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan)
,
Uchida Hiroaki
(Project Division of Cancer Biomolecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
,
Sakuma Yuji
(Department of Molecular Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan)
資料名:
Experimental Cell Research
(Experimental Cell Research)
巻:
413
号:
2
ページ:
Null
発行年:
2022年
JST資料番号:
B0313A
ISSN:
0014-4827
CODEN:
ECREAL
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)